A team of biologists who banded together to support COVID-19 science determined the atomic structure of a coronavirus protein thought to help the pathogen evade and dampen response from human immune cells. The structural map – which is now published in the journal PNAS, but has been open-access for the scientific community since August – has laid the groundwork for new antiviral treatments and enabled further investigations into how the newly emerged virus ravages the human body.
To address PPE shortages during the pandemic, scientists at Berkeley Lab and UC Berkeley are developing a rechargeable, reusable, anti-COVID mask design and a 3D-printable silicon-cast mask mold.
Researchers across the world have already amassed tons of info about COVID-19, and learn more every day. Now, Berkeley Lab experts are developing a platform that puts all this valuable knowledge in one place, and leverages machine learning to make new discoveries.
Our biomanufacturing experts are helping accelerate the development of new COVID-19-fighting technologies. Learn how the scientists at the ABPDU are collaborating with biotech companies to scale up and optimize production of coronavirus-targeting antibodies and a highly accurate rapid testing system.
Even an underground experiment 4,600 feet below a mountain in Central Italy, and a telescope instrument more than a mile high atop an Arizona mountaintop could not escape the impacts of the COVID-19 pandemic. In these videos, a Berkeley Lab scientist and two Berkeley Lab-affiliated researchers share their experiences of working in international collaborations during the COVID-19 pandemic.
Scientists at Berkeley Lab’s Molecular Foundry have joined forces with a research team at Stanford to aim a gene-targeting, antiviral agent called PAC-MAN against COVID-19.
A technology spun from carbon nanotube sensors discovered 20 years ago by Berkeley Lab scientists could one day help health care providers test patients for COVID-19, the disease caused by the coronavirus SARS-CoV-2.
One of the many unanswered scientific questions about COVID-19 is whether it is seasonal like the flu – waning in warm summer months then resurging in the fall and winter. Now scientists at Lawrence Berkeley National Laboratory are launching a project to apply machine-learning methods to a plethora of health and environmental datasets, combined with high-resolution climate models and seasonal forecasts, to tease out the answer.
An international scientific team has discovered a neutralizing antibody, derived from the blood of a SARS survivor, that inhibits the closely related COVID-19-causing coronavirus. In a paper published this week in Nature, the scientists note that the antibody is already on an accelerated development path toward clinical trials.
David Richardson’s job is literally to make sure the light stays on. But it’s not just any light – it’s a very special X-ray light that could play a crucial role in an eventual treatment for COVID-19. Richardson is an operator at the Advanced Light Source, and is one of a handful of workers providing essential services to scientists working on COVID-19-related research.